GlassScriptPhysician profile
Steven Kim
NPI 1275152993
$5,635.15
in general payments reported to CMS, 2019-2025
10 companies · $1,863 in 2025
The $1,863 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,772 · 2025: $1,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,180 · Travel and Lodging: $2,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,179.75 |
| Travel and Lodging | $2,455.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,415.90 | 2024-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $1,872.02 | 2024-2025 | General - Therapies, General - Pain Management, Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $557.13 | 2024-2025 | Evoke |
| Spr Therapeutics, INC | $262.02 | 2025 | Sprint Pns System |
| Ipsen Biopharmaceuticals, INC | $133.92 | 2024 | Dysport |
| Tersera Therapeutics LLC | $114.08 | 2024 | Prialt |
| Mml US, INC. | $111.61 | 2025 | Reactiv8 |
| Curonix LLC | $88.50 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $56.37 | 2024-2025 | Qutenza |
| Globus Medical, INC. | $23.60 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.